Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis

Katrina Wilcox Hagberg,1 Rebecca Persson,1 Catherine Vasilakis-Scaramozza,1 Steve Niemcryk,2 Michael Peng,2 Maria Paris,2 Anders Lindholm,2 Susan Jick1,3 1Boston Collaborative Drug Surveillance Program, Lexington, MA 02421, USA; 2Celgene Corporation, Summit, NJ 07901, USA; 3Boston University School...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Hagberg KW, Persson R, Vasilakis-Scaramozza C, Niemcryk S, Peng M, Paris M, Lindholm A, Jick S
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2020-02-01
श्रृंखला:Clinical Epidemiology
विषय:
apremilast
psoriasis
psoriatic arthritis
herpes zoster
hepatitis c
tuberculosis
ऑनलाइन पहुंच:https://www.dovepress.com/herpes-zoster-hepatitis-c-and-tuberculosis-risk-with-apremilast-compar-peer-reviewed-article-CLEP
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन